Outbreaks

The Measles & Rubella Partnership is a global entity that provides funding and technical support directly to countries to address measles and rubella outbreaks. Through annual funding from Gavi, the Vaccine Alliance, and other supporters the M&RP partners are able to rapidly provide resources to countries experiencing outbreaks for targeted response activities including the purchase of vaccines and operational costs. M&RP has provided technical support to numerous countries working to prevent and stop measles outbreaks. This support is pivotal and sets M&RP and its partners apart, making it all the more unique. In addition to technical support, M&RP Outbreak Response Funds have been provided to the countries in the table below.

Updated SOPs for the Outbreak Response Fund

Countries Receiving M&RP Outbreak Response Funds in 2025

Country	Target Population	Date Approved
Malawi	2,312,531	April 22, 2025
Cambodia	1,046,711	May 27, 2025
Democratic Republic of the Congo	1,903,115	June 2, 2025

Countries with the highest incidence rate of measles per million over the past 12 months

Country	Cases	Rate
Azerbaijan	30,379	2,917.51
Kyrgyzstan	18,072	2,683.16
Kazakhstan	38,522	1,964.74
Yemen	29,623	859.89
Iraq	37,007	813.26
Romania	14,386	723.18
Bosnia and Herzegovina	1,660	517.00
Liberia	1,800	332.20
Burkina Faso	7,003	301.19
South Sudan	3,145	283.62

Measles News

Read the latest news about ongoing immunization campaigns throughout the world.

Interactive map

A dynamic visual aide showing current progress and challenges in the Measles & Rubella Partnership’s campaigns.

2021-2023 Measles Outbreaks Strategic Response Plan (MOSRP)

WHO together with its global and regional MR partners have identified a list of priority countries for enhanced outbreak preparedness and response support as part of the 2021-2023 Measles Outbreaks Strategic Response Plan (MOSRP). The list of priority countries is being regularly revised to account for changes on measles epidemiologic risk. You can find the latest version here.